Predictive Technology Group Inc banner

Predictive Technology Group Inc
OTC:PRED

Watchlist Manager
Predictive Technology Group Inc Logo
Predictive Technology Group Inc
OTC:PRED
Watchlist
Price: 0.0001 USD
Market Cap: $30k

Predictive Technology Group Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Predictive Technology Group Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Predictive Technology Group Inc
OTC:PRED
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other
$47m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other
-$6.5B
CAGR 3-Years
-244%
CAGR 5-Years
-115%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Other
-$10.9B
CAGR 3-Years
-372%
CAGR 5-Years
-161%
CAGR 10-Years
-34%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other
-$371.2m
CAGR 3-Years
-30%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other
-$542.4m
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
-5%
No Stocks Found

Predictive Technology Group Inc
Glance View

Market Cap
30k USD
Industry
Biotechnology

Predictive Technology Group, Inc. engages in the development and commercialization of discoveries and technologies involved in novel molecular diagnostic and pharmaceutical therapeutic and human cells, tissues, and human cellular and tissue-based products. The company is headquartered in Salt Lake City, Utah and currently employs 62 full-time employees. The company went IPO on 2007-07-11. The firm operates through two segments: Human Cell and Tissues Products (HCT/Ps) and diagnostics and therapeutics. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The firm's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. The company offers genetic tests through a number of Advanced Reproductive Technologies (ART) clinics.The Company’s tests include ARTguide and FertilityDX. The RTguide test is a genetic test for women experiencing infertility and other genetic condition.

PRED Intrinsic Value
Not Available

See Also

Back to Top